This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Nov 7;330(17):1696.

doi: 10.1001/jama.2023.17335.

Bempedoic Acid for Primary Prevention of Cardiovascular Events

Mark R Goldstein¹, Luca Mascitelli²

Affiliations

PMID: 37934223
DOI: 10.1001/jama.2023.17335

Comment

Bempedoic Acid for Primary Prevention of Cardiovascular Events

Mark R Goldstein et al. JAMA. 2023.

. 2023 Nov 7;330(17):1696.

doi: 10.1001/jama.2023.17335.

Authors

Mark R Goldstein¹, Luca Mascitelli²

Affiliations

¹ Paoli, Pennsylvania.
² Centro Medico Esperia, Porcia, Italy.

PMID: 37934223
DOI: 10.1001/jama.2023.17335

No abstract available

PubMed Disclaimer

Comment in

Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply.
Nissen SE, Nicholls SJ, Lincoff AM. Nissen SE, et al. JAMA. 2023 Nov 7;330(17):1696-1697. doi: 10.1001/jama.2023.17341. JAMA. 2023. PMID: 37934221 No abstract available.

Comment on

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
Nissen SE, Menon V, Nicholls SJ, Brennan D, Laffin L, Ridker P, Ray KK, Mason D, Kastelein JJP, Cho L, Libby P, Li N, Foody J, Louie MJ, Lincoff AM. Nissen SE, et al. JAMA. 2023 Jul 11;330(2):131-140. doi: 10.1001/jama.2023.9696. JAMA. 2023. PMID: 37354546 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems